Trials / Sponsors / Zhonglin Hao
Zhonglin Hao
Academic / Other · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | ChemoRadiation And Tislelizumab for Esophageal/EGJ Cancer Esophageal Cancer, Esophagogastric Junction Cancer | Phase 2 | 2022-04-01 |
| Completed | Lung Cancer With Copanlisib and Durvalumab Non Small Cell Lung Cancer | Phase 1 | 2021-05-12 |
| Completed | Combination Rucaparib With Nivolumab in Small Cell Lung Carcinoma Small Cell Lung Cancer | Phase 2 | 2019-09-04 |